D. E. Shaw & Co., Inc. Ptc Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,419,539 shares of PTCT stock, worth $64.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,419,539

Holding current value

$64.7 Million

% of portfolio

0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$30.39 - $37.66 $1.88 Million - $2.33 Million	61,901 Added 4.56%	1,419,539 $52.7 Million
Q2 2024 Aug 14, 2024	BUY	$24.69 - $40.12 $3.26 Million - $5.29 Million	131,890 Added 10.76%	1,357,638 $41.5 Million
Q1 2024 May 15, 2024	SELL	$24.15 - $31.95 $2.93 Million - $3.87 Million	-121,219 Reduced 9.0%	1,225,748 $35.7 Million
Q4 2023 Feb 14, 2024	BUY	$18.07 - $29.37 $9.15 Million - $14.9 Million	506,158 Added 60.2%	1,346,967 $37.1 Million
Q3 2023 Nov 14, 2023	BUY	$22.41 - $41.99 $2.42 Million - $4.53 Million	107,821 Added 14.71%	840,809 $18.8 Million
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $1.11 Million - $1.62 Million	27,470 Added 3.89%	732,988 $29.8 Million
Q1 2023 May 15, 2023	SELL	$38.16 - $48.86 $9.13 Million - $11.7 Million	-239,361 Reduced 25.33%	705,518 $34.2 Million
Q4 2022 Feb 14, 2023	SELL	$33.53 - $54.79 $3.66 Million - $5.98 Million	-109,106 Reduced 10.35%	944,879 $36.1 Million
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $4.24 Million - $5.45 Million	101,198 Added 10.62%	1,053,985 $52.9 Million
Q2 2022 Aug 15, 2022	SELL	$25.6 - $45.23 $2.17 Million - $3.83 Million	-84,603 Reduced 8.16%	952,787 $38.2 Million
Q1 2022 May 16, 2022	SELL	$33.33 - $44.6 $5.25 Million - $7.03 Million	-157,590 Reduced 13.19%	1,037,390 $38.7 Million
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $160,994 - $190,588	-4,553 Reduced 0.38%	1,194,980 $47.6 Million
Q3 2021 Nov 15, 2021	SELL	$37.01 - $44.74 $389,567 - $470,933	-10,526 Reduced 0.87%	1,199,533 $44.6 Million
Q2 2021 Aug 16, 2021	BUY	$37.95 - $49.37 $1.56 Million - $2.02 Million	41,004 Added 3.51%	1,210,059 $51.1 Million
Q1 2021 May 17, 2021	BUY	$46.8 - $68.92 $9.15 Million - $13.5 Million	195,412 Added 20.07%	1,169,055 $55.4 Million
Q4 2020 Feb 16, 2021	BUY	$47.96 - $67.64 $4.52 Million - $6.37 Million	94,172 Added 10.71%	973,643 $59.4 Million
Q3 2020 Nov 16, 2020	SELL	$45.41 - $57.07 $685,509 - $861,528	-15,096 Reduced 1.69%	879,471 $41.1 Million
Q2 2020 Aug 14, 2020	SELL	$42.56 - $54.98 $4.32 Million - $5.58 Million	-101,403 Reduced 10.18%	894,567 $45.4 Million
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $2.09 Million - $3.84 Million	-64,616 Reduced 6.09%	995,970 $44.4 Million
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $8.02 Million - $12.5 Million	248,942 Added 30.67%	1,060,586 $50.9 Million
Q3 2019 Nov 14, 2019	SELL	$33.82 - $48.17 $865,047 - $1.23 Million	-25,578 Reduced 3.06%	811,644 $27.5 Million
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $1.61 Million - $2.04 Million	-45,414 Reduced 5.15%	837,222 $37.7 Million
Q1 2019 May 15, 2019	SELL	$28.09 - $39.49 $3.19 Million - $4.48 Million	-113,434 Reduced 11.39%	882,636 $33.2 Million
Q4 2018 Feb 14, 2019	SELL	$29.83 - $46.51 $22.7 Million - $35.4 Million	-760,819 Reduced 43.3%	996,070 $34.2 Million
Q3 2018 Nov 14, 2018	SELL	$33.9 - $47.77 $21.4 Million - $30.1 Million	-630,431 Reduced 26.41%	1,756,889 $82.6 Million
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $1.38 Million - $2.57 Million	53,717 Added 2.3%	2,387,320 $80.5 Million
Q1 2018 May 15, 2018	SELL	$17.46 - $32.59 $4.8 Million - $8.96 Million	-274,829 Reduced 10.54%	2,333,603 $63.1 Million
Q4 2017 Feb 14, 2018	BUY	$15.14 - $20.89 $3.72 Million - $5.13 Million	245,464 Added 10.39%	2,608,432 $43.5 Million
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $39.7 Million - $51.1 Million	2,362,968	2,362,968 $47.3 Million

Others Institutions Holding PTCT

# of Institutions

221

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.26B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account